A Study To Monitor Long-Term Treatment With PF-00547659
Status:
Completed
Trial end date:
2016-07-27
Target enrollment:
Participant gender:
Summary
This study provides open-label drug to eligible patients who have completed a prior study of
PF-00547659. The primary endpoint for this study is long-term safety.